Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health
Posted

Post Expires

Application Deadline

Type

Research/project funding

Reference Number

RFA-DK-21-001

The purpose of this Funding Opportunity Announcement is to promote the development of prognostic, monitoring, and diagnostic biomarkers for diabetic foot ulcers that can be used in clinicaltrials and patient care. This initiative would support early analytical and clinical validation of biomarkers through a phased award to encourage innovative research. The initiative would leverage the resources of the Diabetic Foot Consortium to facilitate the access to well-characterized patients and high-quality human samples. The goal of this initiative is to deliver candidate biomarkers that are ready for definitive analytical and clinical validation studies through the Diabetic Foot Consortium.
Categories: Health, Food and Nutrition.

More Information

Posted

Post Expires

Application Deadline

Type

Research/project funding

Reference Number

RFA-DK-21-001

United States